InsiderDB

Lobbying disclosures · Lobbying report

COR: third_quarter 2026 lobbying report

Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/ Main Street Pharmacy Access Act (H.R. 3164)/ Equitable Community Access to Pharmacist Services Act  (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R 4299) Reimbursement policies impacting drug shortages Part B drug pricing changes Preventing and mitigating generic drug shortages CMS FY 2026 Medicare Part B Physician Fee Schedule Medicare physician reimbursement CY2026 Medicare Physician Fee Schedule Rule

Follow COR
Became public
Oct 20, 2026, 5:07 PM EDT
Event / period date
Not stated
Collected
Nov 11, 2026, 11:07 PM EST

Why this is connected

Exact legal-name match: Cencora, Inc. (https://www.sec.gov/Archives/edgar/data/1140859/).

Reported lobbying amounts

Expenses: $405,804.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/dbeb6be7-244d-45a2-b263-a087a9297e83/","filing_uuid":"dbeb6be7-244d-45a2-b263-a087a9297e83","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/dbeb6be7-244d-45a2-b263-a087a9297e83/print/","filing_document_content_type":"text/html","income":null,"expenses":"405804.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Vivienne E. S. Mitchell","dt_posted":"2026-10-20T17:07:06-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"412 1st Street SE, Suite 200","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":293756,"url":"https://lda.gov/api/v1/registrants/293756/","house_registrant_id":37387,"name":"CENCORA, INC.","description":"Pharmaceutical Distributor","address_1":"412 1st Street SE, Suite 200","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"VIVIENNE E. S. MITCHELL","contact_telephone":"2021343501","dt_updated":"2026-07-21T09:30:16.492929-04:00"},"client":{"id":178667,"url":"https://lda.gov/api/v1/clients/178667/","client_id":12,"name":"CENCORA, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2005-01-05"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/ Main Street Pharmacy Access Act (H.R. 3164)/ Equitable Community Access to Pharmacist Services Act  (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R 4299) Reimbursement policies impacting drug shortages Part B drug pricing changes Preventing and mitigating generic drug shortages CMS FY 2026 Medicare Part B Physician Fee Schedule Medicare physician reimbursement CY2026 Medicare Physician Fee Schedule Rule CMS FY 2027 Medicare Physician Fee Schedule Distributor bona fide service fees Patients First Act of 2026 (H.R.9693)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66284,"prefix":null,"prefix_display":null,"first_name":"VIVIENNE","nickname":null,"middle_name":"STAFFORD","last_name":"MITCHELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142272,"prefix":null,"prefix_display":null,"first_name":"SHELLY","nickname":null,"middle_name":null,"last_name":"MUI-LIPNIK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145130,"prefix":null,"prefix_display":null,"first_name":"DARRELL","nickname":null,"middle_name":null,"last_name":"ROGERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153774,"prefix":null,"prefix_display":null,"first_name":"FREDERICK","nickname":null,"middle_name":null,"last_name":"ESSIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154231,"prefix":"mr","prefix_display":"MR.","first_name":"COREY","nickname":null,"middle_name":"AUSTIN","last_name":"MCGEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Preventing and mitigating generic drug shortages Ensuring Seniors Access to Critical Medications Act/ Main Street Pharmacy Access Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act  (S.2426) Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA) Support for Fair Pharmacy Reimbursement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66284,"prefix":null,"prefix_display":null,"first_name":"VIVIENNE","nickname":null,"middle_name":"STAFFORD","last_name":"MITCHELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142272,"prefix":null,"prefix_display":null,"first_name":"SHELLY","nickname":null,"middle_name":null,"last_name":"MUI-LIPNIK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145130,"prefix":null,"prefix_display":null,"first_name":"DARRELL","nickname":null,"middle_name":null,"last_name":"ROGERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153774,"prefix":null,"prefix_display":null,"first_name":"FREDERICK","nickname":null,"middle_name":null,"last_name":"ESSIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154231,"prefix":"mr","prefix_display":"MR.","first_name":"COREY","nickname":null,"middle_name":"AUSTIN","last_name":"MCGEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Essential Medicines Strategic Stockpile Department of Defense Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Mitigation of Drug Shortages Pharmaceutical supply chain resilience National Defense Authorization Act for Fiscal Year 2027 (NDAA - H.R.8800/S.4784) Supply Chain Resiliency Most Favored Nation drug pricing proposals Direct to consumer pharmacy proposals CMS FY 2026 Medicare Part B Physician Fee Schedule Rule Break Up Big Medicine Act (S. 3822) Stop Corporate Take Over of Physicians Act (H.R.10444/S.5419) Role and value of community specialty physicians and Management Services Organizations (MSOs) NIH Restructuring/National Eye Institute Pandemic and All-Hazards Preparedness/Protecting Americans from All Hazards Preparedness Act (PAHPA) Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66284,"prefix":null,"prefix_display":null,"first_name":"VIVIENNE","nickname":null,"middle_name":"STAFFORD","last_name":"MITCHELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142272,"prefix":null,"prefix_display":null,"first_name":"SHELLY","nickname":null,"middle_name":null,"last_name":"MUI-LIPNIK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145130,"prefix":null,"prefix_display":null,"first_name":"DARRELL","nickname":null,"middle_name":null,"last_name":"ROGERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153774,"prefix":null,"prefix_display":null,"first_name":"FREDERICK","nickname":null,"middle_name":null,"last_name":"ESSIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154231,"prefix":"mr","prefix_display":"MR.","first_name":"COREY","nickname":null,"middle_name":"AUSTIN","last_name":"MCGEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Net CFC Tested Income (NCTI) US Territories Reshoring Tax Policy","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66284,"prefix":null,"prefix_display":null,"first_name":"VIVIENNE","nickname":null,"middle_name":"STAFFORD","last_name":"MITCHELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142272,"prefix":null,"prefix_display":null,"first_name":"SHELLY","nickname":null,"middle_name":null,"last_name":"MUI-LIPNIK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145130,"prefix":null,"prefix_display":null,"first_name":"DARRELL","nickname":null,"middle_name":null,"last_name":"ROGERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153774,"prefix":null,"prefix_display":null,"first_name":"FREDERICK","nickname":null,"middle_name":null,"last_name":"ESSIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154231,"prefix":"mr","prefix_display":"MR.","first_name":"COREY","nickname":null,"middle_name":"AUSTIN","last_name":"MCGEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Tariff proposed policies H.R.2213 - Medical Supply Chain Resiliency Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66284,"prefix":null,"prefix_display":null,"first_name":"VIVIENNE","nickname":null,"middle_name":"STAFFORD","last_name":"MITCHELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145130,"prefix":null,"prefix_display":null,"first_name":"DARRELL","nickname":null,"middle_name":null,"last_name":"ROGERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142272,"prefix":null,"prefix_display":null,"first_name":"SHELLY","nickname":null,"middle_name":null,"last_name":"MUI-LIPNIK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153774,"prefix":null,"prefix_display":null,"first_name":"FREDERICK","nickname":null,"middle_name":null,"last_name":"ESSIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154231,"prefix":"mr","prefix_display":"MR.","first_name":"COREY","nickname":null,"middle_name":"AUSTIN","last_name":"MCGEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in COR

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.